MCU inhibition protects against intestinal ischemia‒reperfusion by inhibiting Drp1-dependent mitochondrial fission

Tulanisa Kadier1, Yi-Guo Zhang1, Yi-Xin Jing1

  • 1Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.

Insights

Mitochondrial calcium overload contributes to intestinal ischemia-reperfusion (IIR) injury. Inhibiting the mitochondrial calcium uniporter (MCU) reduces injury by decreasing oxidative stress, apoptosis, and mitochondrial fission, identifying MCU as a therapeutic target for IIR.

Area of Science:

  • Cell Biology
  • Physiology
  • Pathology

Background:

  • Intestinal ischemia-reperfusion (IIR) injury is a significant surgical complication with limited molecular understanding.
  • Mitochondrial calcium overload is an early indicator of cellular damage and a key factor in IIR.
  • The mitochondrial calcium uniporter (MCU) regulates calcium entry into mitochondria, but its role in IIR is unclear.

Purpose of the Study:

  • To elucidate the specific mechanism of MCU in IIR injury.
  • To investigate MCU as a potential therapeutic target for IIR.

Main Methods:

  • Generation of IIR models in C57BL/6 mice and Caco-2 cells.
  • Assessment of calcium levels and MCU expression.
  • Specific inhibition and knockdown of MCU.
  • Evaluation of mitochondrial function, oxidative stress, and apoptosis.
  • Analysis of Drp1 translocation and mitochondrial fission.

Main Results:

  • IIR injury led to increased intracellular calcium levels and elevated MCU expression.
  • Specific inhibition of MCU significantly attenuated IIR injury.
  • MCU knockdown improved mitochondrial function by reducing oxidative stress and apoptosis.
  • MCU inhibition decreased Drp1 translocation and mitochondrial fission.

Conclusions:

  • MCU plays a critical role in mediating IIR injury.
  • MCU acts as an upstream regulator of Drp1 in the context of IIR.
  • Targeting MCU offers a promising therapeutic strategy for mitigating IIR.